Infectious Disease and Microbiology – Crimean–Congo Hemorrhagic Fever Virus

Overview

Crimean–Congo hemorrhagic fever virus (CCHFV) is a tick-borne enveloped RNA virus that causes a potentially severe viral hemorrhagic fever. It is found across parts of Eastern Europe, Central Asia, the Balkans, the Middle East, and Africa.

Severe disease can involve hepatitis, jaundice, thrombocytopenia, disseminated intravascular coagulation, and major bleeding.

Microbiologic Characteristics

Crimean–Congo hemorrhagic fever virus belongs to the Nairovirus genus.

It is an:

• Enveloped virus

• Single-stranded RNA virus

• Segmented RNA virus

• Virus with helical symmetry

The genome contains three RNA segments.

Epidemiology

CCHFV is transmitted primarily through the bite of infected ticks.

The virus is endemic in several geographic regions, including:

• Eastern Europe

• Central Asia

• The Balkans

• The Middle East

• Africa

People with occupational or environmental exposure to ticks or infected animals are at increased risk.

Transmission

The major route of transmission is:

Tick bite → human infection

Person-to-person spread may also occur through direct exposure to infected blood or body fluids, which is particularly important in healthcare settings.

Clinical Manifestations

Crimean–Congo hemorrhagic fever can range from a nonspecific febrile illness to a severe hemorrhagic syndrome.

Early symptoms may include:

• Fever

• Headache

• Myalgia

• Malaise

• Nausea and vomiting

• Abdominal discomfort

Severe cases may progress rapidly.

Hemorrhagic Fever

The characteristic severe syndrome includes:

• Acute hepatitis

• Jaundice

• Thrombocytopenia

• Disseminated intravascular coagulation

• Petechiae or ecchymoses

• Mucosal bleeding

• Gastrointestinal or other internal bleeding

• Shock

The combination of thrombocytopenia and coagulation abnormalities contributes substantially to the bleeding tendency.

Hepatic Involvement

Acute hepatitis can be prominent.

Patients may develop:

• Markedly elevated liver enzymes

• Jaundice

• Hepatic dysfunction

• Coagulopathy

Severe hepatic injury is associated with a worse prognosis.

Mortality

Severe Crimean–Congo hemorrhagic fever has historically been associated with a high case-fatality rate, often cited around 30–40% in severe cases.

Outcome depends on disease severity, supportive care, and host factors.

Diagnosis

Laboratory diagnosis can include:

• PCR

• Viral antigen detection

• Serologic testing

• Viral culture in specialized laboratories

PCR is especially useful during the acute phase because it directly detects viral nucleic acid.

Infection Control

Patients with suspected or confirmed disease require strict infection-control precautions because transmission can occur through blood and body fluids.

Healthcare workers should use appropriate barrier protection, including gloves, gowns, eye protection, and respiratory protection when indicated by the procedure.

Treatment

Management is primarily supportive.

Treatment may include:

• Fluid and electrolyte management

• Hemodynamic support

• Blood-product replacement when indicated

• Management of coagulopathy

• Organ support in critically ill patients

Antiviral Therapy

There is no universally established specific antiviral treatment with consistently proven benefit.

Supportive care therefore remains the central component of management.

Prevention

Prevention focuses on reducing tick exposure and preventing contact with infected blood or tissues.

Important measures include:

• Tick-bite prevention

• Protective clothing

• Appropriate use of repellents

• Safe handling of animals and animal tissues

• Strict hospital infection-control precautions

• Isolation of affected patients when clinically indicated

Related Bunyavirus Syndromes

Other historically grouped bunyavirus-associated diseases include:

• California encephalitis

• Rift Valley fever

• Hemorrhagic fever with renal syndrome

• Hantavirus pulmonary syndrome

These diseases differ substantially in vectors, reservoirs, geography, and clinical presentation.

High-Yield Clinical Pattern

Tick exposure in an endemic region

• ●

Acute fever

• ●

Thrombocytopenia + hepatitis + bleeding/DIC

→ Think Crimean–Congo hemorrhagic fever

Exam Essentials

Virus: Crimean–Congo hemorrhagic fever virus

Genus: Nairovirus

Genome: Segmented single-stranded RNA

Segments: 3

Envelope: Present

Symmetry: Helical

Vector: Tick

Geography: Eastern Europe, Central Asia, Balkans, Middle East, Africa

Major syndrome: Viral hemorrhagic fever

Key findings: Hepatitis, jaundice, thrombocytopenia, DIC, bleeding

Diagnosis: PCR, antigen detection, serology

Treatment: Primarily supportive

Severe-case mortality: High

Prevention: Tick avoidance and strict infection-control precautions

Key clinical pearl: Tick exposure + hemorrhagic fever + thrombocytopenia + hepatitis + DIC is the classic pattern for Crimean–Congo hemorrhagic fever.